These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1527035)

  • 1. Pseudomonas aeruginosa exotoxin A interaction with eucaryotic elongation factor 2. Role of the His426 residue.
    Kessler SP; Galloway DR
    J Biol Chem; 1992 Sep; 267(27):19107-11. PubMed ID: 1527035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical analysis of Pseudomonas aeruginosa exotoxin A. Analysis of the His426 determinant.
    McGowan JL; Kessler SP; Anderson DC; Galloway DR
    J Biol Chem; 1991 Mar; 266(8):4911-6. PubMed ID: 1705936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical analysis of CRM 66. A nonfunctional Pseudomonas aeruginosa exotoxin A.
    Galloway DR; Hedstrom RC; McGowan JL; Kessler SP; Wozniak DJ
    J Biol Chem; 1989 Sep; 264(25):14869-73. PubMed ID: 2504713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An enzyme-linked immunosorbent assay for the association of the catalytic domain of diphthamide-specific ribosyltransferases to eukaryotic elongation factor-2.
    Prentice GA; Merrill AR
    Anal Biochem; 1999 Aug; 272(2):216-23. PubMed ID: 10415091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active site mutations of Pseudomonas aeruginosa exotoxin A. Analysis of the His440 residue.
    Han XY; Galloway DR
    J Biol Chem; 1995 Jan; 270(2):679-84. PubMed ID: 7822295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 7. Crystal structure of the catalytic domain of Pseudomonas exotoxin A complexed with a nicotinamide adenine dinucleotide analog: implications for the activation process and for ADP ribosylation.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6902-6. PubMed ID: 8692916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. His-426 of the Pseudomonas aeruginosa exotoxin A is required for ADP-ribosylation of elongation factor II.
    Wozniak DJ; Hsu LY; Galloway DR
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):8880-4. PubMed ID: 3143111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa exotoxin A: effects of mutating tyrosine-470 and tyrosine-481 to phenylalanine.
    Lukac M; Collier RJ
    Biochemistry; 1988 Oct; 27(20):7629-32. PubMed ID: 2849995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular ADP-ribosyltransferase with the same mechanism of action as diphtheria toxin and Pseudomonas toxin A.
    Lee H; Iglewski WJ
    Proc Natl Acad Sci U S A; 1984 May; 81(9):2703-7. PubMed ID: 6326138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-function analysis of water-soluble inhibitors of the catalytic domain of exotoxin A from Pseudomonas aeruginosa.
    Yates SP; Taylor PL; Jørgensen R; Ferraris D; Zhang J; Andersen GR; Merrill AR
    Biochem J; 2005 Feb; 385(Pt 3):667-75. PubMed ID: 15458385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of Pseudomonas aeruginosa exotoxin domain III with nicotinamide and AMP: conformational differences with the intact exotoxin.
    Li M; Dyda F; Benhar I; Pastan I; Davies DR
    Proc Natl Acad Sci U S A; 1995 Sep; 92(20):9308-12. PubMed ID: 7568123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exotoxin A-eEF2 complex structure indicates ADP ribosylation by ribosome mimicry.
    Jørgensen R; Merrill AR; Yates SP; Marquez VE; Schwan AL; Boesen T; Andersen GR
    Nature; 2005 Aug; 436(7053):979-84. PubMed ID: 16107839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.
    Elzaim HS; Chopra AK; Peterson JW; Goodheart R; Heggers JP
    Infect Immun; 1998 May; 66(5):2170-9. PubMed ID: 9573104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a fluorometric assay for characterization of the catalytic competency of a domain III fragment of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Anal Biochem; 2001 May; 292(1):26-33. PubMed ID: 11319814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC
    J Bacteriol; 1993 Feb; 175(3):898-901. PubMed ID: 8423159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.
    Rutault K; Vacheron MJ; Guinand M; Michel G
    Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation into the catalytic role for the tryptophan residues within domain III of Pseudomonas aeruginosa exotoxin A.
    Beattie BK; Prentice GA; Merrill AR
    Biochemistry; 1996 Dec; 35(48):15134-42. PubMed ID: 8952460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
    Armstrong S; Merrill AR
    Biochemistry; 2004 Jan; 43(1):183-94. PubMed ID: 14705944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping the enzymatic active site of Pseudomonas aeruginosa exotoxin A.
    Brandhuber BJ; Allured VS; Falbel TG; McKay DB
    Proteins; 1988; 3(3):146-54. PubMed ID: 3151219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.